HomeOTLC • OTCMKTS
add
Oncotelic Therapeutics Inc
Previous close
$0.041
Day range
$0.036 - $0.042
Year range
$0.010 - $0.053
Market cap
17.12M USD
Avg Volume
67.70K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 113.46K | -72.63% |
Net income | -735.98K | 86.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -110.25K | 73.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 170.40K | -29.42% |
Total assets | 30.01M | -16.89% |
Total liabilities | 18.40M | 8.75% |
Total equity | 11.61M | — |
Shares outstanding | 399.68M | — |
Price to book | 1.36 | — |
Return on assets | -0.94% | — |
Return on capital | -1.17% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -735.98K | 86.09% |
Cash from operations | -372.62K | -361.85% |
Cash from investing | — | — |
Cash from financing | 275.00K | 302.93% |
Net change in cash | -97.62K | -685.33% |
Free cash flow | 299.64K | 146.70% |
About
Founded
1988
Headquarters
Website
Employees
22